Advanced Heart Health Panel
This Advanced Heart Health blood test panel combines lipids, ApoB, Lp(a), inflammation, and metabolic markers to clarify cardiovascular risk patterns.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is a lab panel, not a single cholesterol number. The Advanced Heart Health panel pulls together multiple blood markers that describe how many atherogenic particles you carry, whether inherited risk like lipoprotein(a) may be in play, and whether inflammation or metabolic patterns are likely pushing risk higher than your basic lipid panel suggests.
If you have a family history of early heart attack or stroke, you are trying to make sense of “lipid jargon,” or you are on medications like statins and want clearer feedback than LDL alone, this panel is designed to give you a more complete pattern to discuss with your clinician.
Do I need this panel?
You may benefit from the Advanced Heart Health panel if your standard lipid panel feels incomplete—especially when your LDL cholesterol looks “fine” but you still have a strong family history of cardiovascular disease, or you have already had a cardiac event and want tighter risk tracking.
This panel can also be useful if you have been told you have high triglycerides, low HDL, insulin resistance, fatty liver risk, or metabolic syndrome features. Those patterns often change the meaning of LDL and non-HDL cholesterol, and they can point to different next steps than “just lower LDL.”
If you recently learned your lipoprotein(a) (Lp(a)) is elevated, this panel helps you place that inherited risk in context with particle-related markers (like ApoB) and inflammation signals (like hs-CRP), which can influence how aggressively you and your clinician manage overall risk.
Lab testing supports clinician-directed care and shared decision-making, but it cannot diagnose a heart condition on its own. Your symptoms, blood pressure, imaging, medications, and personal history still matter when you interpret a multi-marker panel.
This panel combines several standardized blood tests; reference ranges and clinical decision thresholds can vary by lab and by your personal risk category.
Lab testing
Order labs to measure Advanced Heart Health Panel
from $216.37 at Quest Diagnostics
About 1 week
Schedule online — results typically within a week
Clear next steps
Guidance included, with follow-up care available
HSA / FSA
Eligible for pre-tax health spending accounts
Get this panel with Vitals Vault
Vitals Vault lets you order the Advanced Heart Health panel and get a single, organized set of results that you can trend over time. Because this is a bundle, you avoid piecemeal ordering and you get a pattern that is easier to interpret than isolated numbers.
After your results are in, PocketMD can help you translate the panel into plain language: which markers are most important for your situation, which results move together, and which follow-up questions to bring to your next appointment. This is especially helpful when you are deciding whether LDL, ApoB, triglycerides, Lp(a), and inflammation are telling the same story—or different ones.
If you are already making changes (nutrition, weight loss, exercise, sleep, alcohol reduction) or you are on heart medications, you can use repeat testing to see whether the pattern is improving, not just one headline number.
- One blood draw with multiple cardiovascular-relevant markers
- Results you can save and compare over time
- PocketMD support to integrate the full pattern (not just LDL)
Key benefits of Advanced Heart Health panel testing
- Clarifies “particle risk” by pairing traditional cholesterol values with ApoB and related ratios.
- Screens for inherited risk with lipoprotein(a) (Lp(a)), a common reason risk can be underestimated.
- Adds inflammation context (such as hs-CRP) that can change how aggressively risk is managed.
- Helps explain confusing lipid patterns like normal LDL with high triglycerides or low HDL.
- Supports medication monitoring by showing whether therapy is lowering atherogenic particle burden, not only LDL cholesterol.
- Improves conversations with your clinician by putting multiple risk signals in one place.
- Makes retesting more actionable by tracking a pattern across markers rather than chasing a single number.
What is the Advanced Heart Health panel?
The Advanced Heart Health panel is a bundled set of blood tests that looks at cardiovascular risk from several angles at once. A basic lipid panel focuses on cholesterol carried in the blood (LDL-C, HDL-C, triglycerides, and total cholesterol). This panel goes further by adding markers that estimate how many atherogenic (plaque-forming) particles you have, whether inherited lipoproteins are contributing to risk, and whether inflammation or metabolic stress may be raising risk beyond what cholesterol alone suggests.
A useful way to think about this panel is that it answers three practical questions:
First, “How many atherogenic particles are circulating?” LDL cholesterol is the amount of cholesterol inside LDL particles, but the number of particles can be more directly reflected by apolipoprotein B (ApoB), because most atherogenic particles carry one ApoB molecule.
Second, “Is there inherited risk that won’t respond much to lifestyle?” Lipoprotein(a) is largely genetic and can be elevated even when the rest of your lipids look healthy. Knowing your Lp(a) can change how you prioritize other risk reducers.
Third, “Is the environment in your body more likely to promote plaque growth or instability?” Inflammation markers (like high-sensitivity C-reactive protein, hs-CRP) and metabolic markers (like glucose control) can help explain why two people with similar LDL can have very different outcomes.
Because this is a panel, you get the most value when you interpret the results together. A single abnormal result may matter less (or more) depending on what the other markers show and on your personal history.
What do my panel results mean?
Lower-risk patterns across the panel
A generally favorable pattern is when atherogenic particle markers are low (for example, ApoB and non-HDL cholesterol are not elevated), triglycerides are not high, and inflammation markers like hs-CRP are low. In that setting, LDL cholesterol that is modestly elevated may still warrant attention, but it is less likely to reflect a high particle burden. If Lp(a) is low, you also have less inherited “baseline” risk pushing the system in the wrong direction. Your clinician may focus on maintaining the pattern with lifestyle, blood pressure control, and periodic retesting based on your overall risk profile.
Optimal patterns (what “good” looks like in context)
An optimal panel is internally consistent: cholesterol measures, particle-related markers, and inflammation/metabolic markers all point in the same low-risk direction. Typically, that means ApoB aligns with LDL-C and non-HDL-C (no hidden particle excess), triglycerides are in a healthy range, HDL is not extremely low, and hs-CRP is low. If Lp(a) is elevated but everything else is well controlled, the “optimal” goal often shifts toward being more aggressive with the modifiable parts of risk (ApoB/non-HDL, blood pressure, glucose control, smoking avoidance), because Lp(a) itself is harder to change.
Higher-risk patterns that deserve follow-up
Higher-risk patterns often show up as a mismatch or clustering of abnormalities: ApoB higher than expected for your LDL-C (suggesting more atherogenic particles than LDL alone implies), high triglycerides with low HDL (often tied to insulin resistance), and/or elevated hs-CRP (suggesting more inflammatory activity). A high Lp(a) can amplify concern even when other markers are only mildly abnormal, especially with a family history of early heart disease. If several markers are elevated at once, your clinician may discuss earlier or more intensive risk reduction, additional testing (such as imaging or secondary-cause evaluation), and a clearer retesting schedule to confirm improvement.
Factors that influence panel markers
Many results in this panel shift with recent illness, weight change, alcohol intake, and medication use. Triglycerides can rise after higher-carb meals, alcohol, or poorly controlled diabetes; hs-CRP can rise after infection, injury, or chronic inflammatory conditions; and LDL-related markers can change with thyroid status, diet composition, and lipid-lowering therapy. Lp(a) is mostly genetic and tends to be stable over time, so a single measurement is often informative, but interpretation still depends on your overall risk. Because multiple markers can move in different directions, it helps to interpret trends (repeat testing) and to review your medications and recent health events when a result looks surprising.
What’s included in this panel
- Arachidonic Acid
- Arachidonic Acid/Epa Ratio
- C-Peptide, Lc/Ms/Ms
- Dha
- Dpa
- Epa
- Epa+Dpa+Dha
- Fibrinogen Antigen, Nephelometry
- Hdl Large
- Insulin, Intact, Lc/Ms/Ms
- Insulin Resistance Score
- Ldl Medium
- Ldl Particle Number
- Ldl Pattern
- Ldl Peak Size
- Ldl Small
- Linoleic Acid
- Lp Pla2 Activity
- Omega-3 Total
- Omega-6/Omega-3 Ratio
- Omega-6 Total
Similar lab panels to consider
Frequently Asked Questions
Is this the same as a standard lipid panel?
No. A standard lipid panel usually includes total cholesterol, LDL-C, HDL-C, and triglycerides. The Advanced Heart Health panel is a broader lab panel that adds deeper risk markers (such as ApoB and Lp(a)) and supporting context (such as inflammation and metabolic markers) so you can interpret the lipid picture more completely.
Do I need to fast for this panel?
Fasting is often recommended because triglycerides and insulin-related markers can be more interpretable when you have not eaten for about 8–12 hours. If you cannot fast, you can still test, but you should interpret triglycerides and insulin with extra caution and consider repeating under fasting conditions for trend accuracy.
How do I interpret ApoB versus LDL cholesterol?
LDL-C is the amount of cholesterol carried inside LDL particles, while ApoB is a proxy for the number of atherogenic particles (LDL and related particles). If ApoB is higher than expected for your LDL-C, it can suggest you have more particles carrying less cholesterol each—an important pattern in insulin resistance and high triglycerides. Your clinician may prioritize lowering ApoB/non-HDL as a more direct way to reduce particle burden.
If my Lp(a) is high, does that mean I will have a heart attack?
A high Lp(a) does not guarantee a heart attack, but it can raise baseline cardiovascular risk because it is an inherited, atherogenic lipoprotein. The practical takeaway is usually to control the modifiable parts of risk more tightly (ApoB/non-HDL, blood pressure, glucose, smoking avoidance) and to discuss individualized targets and follow-up with your clinician.
How often should I repeat an advanced heart health panel?
Retesting depends on why you ordered it. If you are starting or changing lipid-lowering therapy or making major lifestyle changes, many people recheck key markers in about 8–12 weeks to confirm direction and adherence. If you are stable, your clinician may recommend less frequent monitoring. Lp(a) is often stable and may not need frequent repeats, while ApoB, triglycerides, and hs-CRP can be useful to trend.
Should I order this panel or order tests individually?
If your goal is to understand cardiovascular risk patterns, a panel is usually more useful than individual tests because the interpretation depends on how markers relate to each other (for example, LDL-C versus ApoB, triglycerides versus HDL, and inflammation context). Individual tests can make sense when you already know exactly what you need to monitor (such as a quick ApoB recheck), but the panel is often the better starting point.
Can medications change these results?
Yes. Statins and other lipid-lowering therapies can lower LDL-C and often ApoB; some medications can raise or lower triglycerides; and anti-inflammatory treatments or recent infections can change hs-CRP. Always interpret your results alongside your current medication list and any recent illness, and do not stop or change prescriptions based on labs without clinician guidance.